Drinking coffee or tea may be beneficial for physical function in ageing   

04 Sep 2024

NUS artificial intelligence platform demonstrates promising results in effectively treating a patient with a rare cancer

In a first-of-its-kind clinical trial, a team at the NUS Yong Loo Lin School of Medicine leveraged an artificial intelligence-derived platform to guide treatment for a patient with a rare blood cancer.

23 Aug 2024

Trimedsoc Alliance Renews Collaboration to Unify Voice of Singapore Medical Students

This alliance by the student bodies of Singapore’s three medical schools continues to unify and represent the voice of the local medical student community through regular dialogue, engagement and collaboration with external stakeholders, including the Singapore Medical Association and Ministry of Health.

17 Aug 2024

AI and Digital healthcare solutions sweep awards at Medical Grand Challenge 2024

A machine learning software that allows nurses to efficiently and remotely monitor outpatient stoma cases while providing personalised care advice, and a digital intervention where women can find personalised, comprehensive and accessible mental health care won first place in the Nascent and Open categories respectively at the Medical Grand Challenge Finale 2024, held earlier today.

16 Aug 2024

Heat exposure can affect hormones

A multi-disciplinary team of researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), University of Oxford, the London School of Hygiene & Tropical Medicine, and the William Harvey Research Institute (WHRI) at Queen Mary University of London, has stressed the urgent need for further research into the effects of heat exposure on the endocrine system.

13 Aug 2024

Singapore Researchers Discover New Candida auris – A Possible Global Public Health Threat

Researchers from the Singapore General Hospital (SGH), A*STAR’s Genome Institute of Singapore (GIS) and Yong Loo Lin School of Medicine at National University of Singapore (NUS Medicine) have discovered a new clade (or type) of Candida auris, bringing the number of clades known globally to a total of six.

05 Aug 2024

Significant discrepancies between actual and labelled amount of anti-ageing ingredients in supplements: NUS Medicine study

How do we know if the supplements we consume are giving us the right amount of ingredients as stated on their labels at the point of sale? Many of these anti-ageing (also called geroprotector) ingredients such as Nicotinamide Mononucleotide (NMN) and Urolithin A are included to promote cell repair and improve muscle function and strength.

31 Jul 2024

Clinical ageing clocks: NUS and SGH develop algorithm-powered tests to indicate mortality risk

A few tubes of blood, a urine test and a health questionnaire to determine a person’s biological age are all that is needed to indicate one’s future risk of mortality. A new class of clinical ageing clocks using these tests has emerged – PCAge and LinAge – which outline the healthy and unhealthy ageing trajectories and provide a new way to test ageing intervention strategies.

22 Jul 2024

Boosting fruit intake during midlife can ward off late-life blues: NUS study

In a large Singapore cohort study involving over 13,000 participants spanning close to 20 years, higher consumption of fruits during midlife was found to be associated with lower odds of depressive symptoms at late-life

17 Jul 2024

New research reveals link between spinal muscular atrophy (SMA) and liver damage.

An international study has discovered that people living with the neurodegenerative condition Spinal Muscular Atrophy (SMA) are at higher risk of developing fatty liver disease, suggesting that SMA patients may face additional health problems over time. This finding raises significant concerns about long-term care and health outcomes for individuals with SMA.

01 Jul 2024

NUS Medicine and 22Health Ventures announce joint healthtech accelerator

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and 22Health Ventures, an early-stage healthtech investment firm (22Health), announced their joint accelerator programme, NUS Medicine Digital Advanced Technology Accelerator (DATA), an NUS Medicine – 22Health Ventures partnership (the Accelerator).